RPX’s CEO released a statement on our response to the COVID-19 emergency. Click here to access.

RPX’s CEO released a statement on our response to the COVID-19 emergency. Click here to access.

Transcutaneous analyte sensor

  • US 8,515,519 B2
  • Filed: 02/26/2009
  • Issued: 08/20/2013
  • Est. Priority Date: 07/13/2004
  • Status: Active Grant
  • ×

    Create Patent Alert


    *Certain alert events are not available for your current subscription level. Upgrade
  • Save